Count on highest quality biospecimens and clinical data
in the world’s most comprehensive multi-omics cancer database.
What makes this database so unique?
High-quality specimens
By maintaining close partnerships with clinical institutions all over the world, we are able to collect biospecimens and comprehensive clinical information of the highest possible quality.
With Onco AI-Med, the Oncology Alliance for Individualized Medicine, we have also established a collaborative network of leading hospitals to conduct cancer research based on IndivuType.
Clinical and follow-up data
Fresh frozen tissue
Liquid Samples
Multi-omics data generation
Based on next-generation sequencing and mass spectrometry technologies, we extract the deepest possible molecular information from tissue samples.
In-depth data processing
The raw data is quality controlled and processed with state-of-the-art technology and infrastructure, making it ready for cloud-based AI analysis.
The global multi-omics cancer database
Through the IndivuType Database, we provide researchers with a library of thousands of cases utilizing the most unique and complex high-quality data sets. It constitutes an unparalleled resource with which to speed up discovery and development.
- Digital pathology image data
- Data available for tumor/normal pairs
- Broad coverage of major human cancers, including: crc, nsclc, breast, gastric, liver, kidney
- Thousands of cancer cases
- Worldwide collection network
- Clinical and follow-up information
- Multi-omics data
Phospho-
proteomics
Whole-Protein Proteomics
Transcript-
omics
MicroRNAs
Whole Genome Sequencing
Start finding truly
novel insights now
In order to truly individualize cancer therapy, our service can be adapted to your project requirements. We have successfully established partnerships with small biotech as well as large pharmaceutical companies and prestigious academic institutions, both enhancing R&D activities and launching new discovery programs.